Zepeng “Phoenix” Mu
banner
zpmu.bsky.social
Zepeng “Phoenix” Mu
@zpmu.bsky.social
Postdoc working on immunogenomics and CRISPR with @soumya-boston.bsky.social
Reposted by Zepeng “Phoenix” Mu
So excited to share our latest study on defining the function of disease variants by editing single cells, and assuming them with CRAFT-seq! Special thanks to @zpmu.bsky.social and @baglaenkolab.bsky.social! @broadinstitute.org

www.nature.com/articles/s41...
Precisely defining disease variant effects in CRISPR-edited single cells - Nature
A plate-based assay called CRAFTseq has been developed that uses ‘multi-omic’ single-cell RNA sequencing and direct genotyping of CRISPR edits to test the functional effects of genetic variants o...
www.nature.com
July 23, 2025 at 11:34 PM
Reposted by Zepeng “Phoenix” Mu
📣Excited to share my last postdoc paper with
@soumya-boston.bsky.social on eQTL mechanisms depending on where the RNA is in the cell! @broadinstitute.org @harvardmed.bsky.social
TL;DR:Early RNA eQTL variants in the nucleus and late RNA eQTL variants in the cytosol have distinct molecular mechanism🧵
February 27, 2025 at 2:21 AM
First Bluesky post! Excited to share the final chapter of my PhD research! We performed a large- scale and thorough scATAC QTL analysis in PBMC, and gained insight on how caQTL can help us better understand disease GWAS and inform future study design.
Impact of disease-associated chromatin accessibility QTLs across immune cell types and contexts https://www.medrxiv.org/content/10.1101/2024.12.05.24318552v1
December 14, 2024 at 2:33 PM